Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 24, 2007 - Issue 1
Submit an article Journal homepage
119
Views
13
CrossRef citations to date
0
Altmetric
Case Reports

USE OF RECOMBINANT ERYTHROPOIETIN FOR THE MANAGEMENT OF SEVERE HEMOLYTIC DISEASE OF THE NEWBORN OF A K0 PHENOTYPE MOTHER

Antonia Manoura Department of Neonatology, University of Crete, Crete, Greece
,
Eftychia Korakaki Department of Neonatology, University of Crete, Crete, Greece
,
Eleftheria Hatzidaki Department of Neonatology, University of Crete, Crete, Greece
,
Emmanuel Saitakis Department of Neonatology, University of Crete, Crete, Greece
,
Sofia Maraka Department of Neonatology, University of Crete, Crete, Greece
,
Isabella Papamastoraki Department of Neonatology, University of Crete, Crete, Greece
,
Emmanuel Matalliotakis Department of Transfusion Medicine, University of Crete, Crete, Greece
,
Kaliopi Foundouli Department of Transfusion Medicine, University of Crete, Crete, Greece
&
Christine Giannakopoulou Department of Neonatology, University of Crete, Crete, Greece
 show all
Pages 69-73 | Received 23 May 2006, Accepted 23 Aug 2006, Published online: 09 Jul 2009

REFERENCES

  • Kenneth J, Moise J R. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000; 92: 75–81
  • Redman C M, Marsh L W. The Kell blood group system and the McLeod phenotype. Semin Hematol 1993; 30: 209–218, [INFOTRIEVE]
  • Fourmaintaux A, Vitrac D, Mariette J B, Brunel F. Phenotype Ko et allo-immunisation foeto-maternelle. Arch Fr Pediatr 1993; 50: 779–781
  • Giannakopoulou C, Relakis K, Kalmanti M. Severe anemia due to Kell alloimmunization. Hematologia 1997; 28: 173–175
  • Vaughan J I, Warwick R M, Letsky E A, Nicolini U, Rodeck C H, Fisk N M. Erythropoietic suppression in fetal anemia because of Kell alloimunization. Am J Obstet Gynecol 1994; 171: 247–252, [INFOTRIEVE]
  • Weiner C P, Widness J A. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174: 547–551, [INFOTRIEVE], [CROSSREF]
  • McKenna D S, Nagaraja H N, O'Shaughnessy R. Management of pregnancies complicated by anti-Kell isoimmunization. Obstet Gynecol 1999; 93: 667–673, [INFOTRIEVE], [CROSSREF]
  • Millard D, Gidding S, Socol M, et al. Stockman III JA. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990; 117: 447–454, [INFOTRIEVE], [CROSSREF]
  • Ovali F, Samanci N, Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996; 39: 831–834, [INFOTRIEVE]
  • Dhodapkar K M, Blei F. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 2001; 23: 69–70, [INFOTRIEVE], [CROSSREF]
  • Lydaki E, Nikoloudi I, Kaminopetros P, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion 2005; 45: 1791–1795, [INFOTRIEVE], [CROSSREF]
  • Southcott M, Tanner M, Anstee D. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999; 93: 4425–4435, [INFOTRIEVE]
  • Vaughan J I, Manning M, Warwick R M, Letsky E A, Murray N A, Roberts I AG. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798–803, [INFOTRIEVE], [CROSSREF]
  • Luban N LC. Hemolytic disease of the newborn: progenitor cells and late effects. N Engl J Med 1998; 338: 830–831, [INFOTRIEVE], [CROSSREF]
  • Smoleniec J, Anderson N, Poole G. Hydrops fetalis caused by a blood group antibody usually undetected in routine screening. Arch Dis Child 1994; 71: F216–F217

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.